| scholarly article | Q13442814 |
| P2093 | author name string | Antoinette Hollestelle | |
| John W M Martens | |||
| Mahdi Rivandi | |||
| P2860 | cites work | Epigenome-wide association study in the European Prospective Investigation into Cancer and Nutrition (EPIC-Turin) identifies novel genetic loci associated with smoking | Q57054077 |
| Common variants on chromosome 5p12 confer susceptibility to estrogen receptor–positive breast cancer | Q57251792 | ||
| Epigenome-wide methylation in DNA from peripheral blood as a marker of risk for breast cancer | Q57265567 | ||
| The emerging landscape of breast cancer susceptibility | Q57272203 | ||
| A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer | Q57305942 | ||
| Association of Polygenic Risk Scores for Multiple Cancers in a Phenome-wide Study: Results from The Michigan Genomics Initiative | Q57612089 | ||
| Germline mutations 657del5 of the NBS1 gene contribute significantly to the incidence of breast cancer in Central Poland | Q83980725 | ||
| Evaluating the power to discriminate between highly correlated SNPs in genetic association studies | Q84488690 | ||
| An integrated encyclopedia of DNA elements in the human genome | Q22122150 | ||
| The accessible chromatin landscape of the human genome | Q24595581 | ||
| PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene | Q24615080 | ||
| Genome-wide association studies identify four ER negative-specific breast cancer risk loci | Q24622610 | ||
| Comprehensive molecular portraits of human breast tumours | Q24630844 | ||
| RNA sequencing reveals the role of splicing polymorphisms in regulating human gene expression | Q24630966 | ||
| Genome-wide association study identifies novel breast cancer susceptibility loci | Q24645441 | ||
| A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity | Q24669850 | ||
| A global reference for human genetic variation | Q25909434 | ||
| Beyond editing: repurposing CRISPR-Cas9 for precision genome regulation and interrogation | Q26775746 | ||
| A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 | Q28115843 | ||
| Capturing chromosome conformation | Q28201750 | ||
| Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations | Q28215462 | ||
| An expansive human regulatory lexicon encoded in transcription factor footprints | Q28274429 | ||
| Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease | Q28284509 | ||
| A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer | Q28303909 | ||
| Genome-wide association study in east Asians identifies novel susceptibility loci for breast cancer | Q28924377 | ||
| A genome-wide association study identifies a breast cancer risk variant in ERBB4 at 2q34: results from the Seoul Breast Cancer Study | Q28943473 | ||
| Large-scale genotyping identifies 41 new loci associated with breast cancer risk | Q29416989 | ||
| Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer | Q29417100 | ||
| An oestrogen-receptor-α-bound human chromatin interactome | Q29541719 | ||
| Landscape of transcription in human cells | Q29547467 | ||
| RNA-guided genetic silencing systems in bacteria and archaea | Q29614421 | ||
| The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups | Q29614700 | ||
| Annotation of functional variation in personal genomes using RegulomeDB | Q29614867 | ||
| Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. | Q37367871 | ||
| Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. | Q37369631 | ||
| The 5p12 breast cancer susceptibility locus affects MRPS30 expression in estrogen-receptor positive tumors | Q37661498 | ||
| Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21. | Q37684672 | ||
| Discovering moderate-risk breast cancer susceptibility genes | Q37719902 | ||
| Genetic modifiers of CHEK2*1100delC-associated breast cancer risk | Q37739048 | ||
| From candidate gene studies to GWAS and post-GWAS analyses in breast cancer | Q38366358 | ||
| Strategies for fine-mapping complex traits | Q38544247 | ||
| Long Noncoding RNAs CUPID1 and CUPID2 Mediate Breast Cancer Risk at 11q13 by Modulating the Response to DNA Damage. | Q38640565 | ||
| Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study | Q38787080 | ||
| Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study | Q39006292 | ||
| Precision genome editing in the CRISPR era. | Q39126189 | ||
| Genome-wide association study in East Asians identifies two novel breast cancer susceptibility loci | Q39647103 | ||
| Global patterns of cis variation in human cells revealed by high-density allelic expression analysis | Q39786256 | ||
| Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines | Q39826410 | ||
| Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer | Q39844032 | ||
| DNA methylome analysis identifies accelerated epigenetic ageing associated with postmenopausal breast cancer susceptibility | Q40308621 | ||
| Epigenome-wide association studies for breast cancer risk and risk factors | Q41695097 | ||
| Electrophoretic mobility shift assay (EMSA) for detecting protein-nucleic acid interactions | Q41902384 | ||
| Identification of breast cancer associated variants that modulate transcription factor binding. | Q42366138 | ||
| Pathway-based discovery of genetic interactions in breast cancer | Q42366151 | ||
| Functional dissection of breast cancer risk-associated TERT promoter variants | Q42366538 | ||
| Epigenomic annotation of genetic variants using the Roadmap Epigenome Browser | Q42432452 | ||
| Association analysis identifies 65 new breast cancer risk loci. | Q45979098 | ||
| Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer | Q46103372 | ||
| Genetic effects on gene expression across human tissues | Q46285732 | ||
| Common Genetic Variation and Breast Cancer Risk - Past, present, and future | Q47703662 | ||
| Common regulatory variation impacts gene expression in a cell type-dependent manner | Q29614882 | ||
| HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants | Q29614906 | ||
| The long-range interaction landscape of gene promoters | Q29615403 | ||
| Integrative analysis of 111 reference human epigenomes | Q29615565 | ||
| Identification of the breast cancer susceptibility gene BRCA2 | Q29616290 | ||
| Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease | Q30665466 | ||
| Software tools for visualizing Hi-C data | Q31159453 | ||
| Bioluminescent assays for high-throughput screening | Q33278115 | ||
| Allele-specific up-regulation of FGFR2 increases susceptibility to breast cancer | Q33332300 | ||
| Cis-eQTL-based trans-ethnic meta-analysis reveals novel genes associated with breast cancer risk. | Q33565679 | ||
| Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers | Q33614244 | ||
| Ancestry-shift refinement mapping of the C6orf97-ESR1 breast cancer susceptibility locus | Q33641475 | ||
| Applications of the 1000 Genomes Project resources | Q33711909 | ||
| Quantifying the underestimation of relative risks from genome-wide association studies | Q33855679 | ||
| Fine scale mapping of the breast cancer 16q12 locus | Q33878276 | ||
| Analysis of Case-Control Association Studies: SNPs, Imputation and Haplotypes | Q33904106 | ||
| A BRCA1-mutation associated DNA methylation signature in blood cells predicts sporadic breast cancer incidence and survival | Q33948754 | ||
| 8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC. | Q34006369 | ||
| Genome-wide association analysis in East Asians identifies breast cancer susceptibility loci at 1q32.1, 5q14.3 and 15q26.1. | Q34023796 | ||
| Functional polymorphisms in the TERT promoter are associated with risk of serous epithelial ovarian and breast cancers | Q34031757 | ||
| A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). | Q34085748 | ||
| The current state of chromatin immunoprecipitation | Q34092981 | ||
| Genome-wide association study identifies five new breast cancer susceptibility loci | Q34114293 | ||
| Unraveling the regulatory mechanisms underlying tissue-dependent genetic variation of gene expression | Q34139984 | ||
| Firefly luciferase as a tool in molecular and cell biology | Q34165114 | ||
| Integrative eQTL-based analyses reveal the biology of breast cancer risk loci | Q34194768 | ||
| FunciSNP: an R/bioconductor tool integrating functional non-coding data sets with genetic association studies to identify candidate regulatory SNPs | Q34298932 | ||
| Genetics of human gene expression: mapping DNA variants that influence gene expression | Q34339168 | ||
| The contribution of RNA decay quantitative trait loci to inter-individual variation in steady-state gene expression levels | Q34446672 | ||
| Advantages of firefly luciferase as a reporter gene: application to the interleukin-2 gene promoter | Q34544864 | ||
| ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles | Q34546389 | ||
| Human disease-associated genetic variation impacts large intergenic non-coding RNA expression | Q34558052 | ||
| Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer | Q34631785 | ||
| Replication and functional genomic analyses of the breast cancer susceptibility locus at 6q25.1 generalize its importance in women of chinese, Japanese, and European ancestry | Q34870700 | ||
| Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1. | Q34903062 | ||
| Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation | Q35064451 | ||
| Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk | Q35102646 | ||
| Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2. | Q35524465 | ||
| Genome-wide association study identifies breast cancer risk variant at 10q21.2: results from the Asia Breast Cancer Consortium | Q35565707 | ||
| A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer | Q35755874 | ||
| Epigenome-wide association study reveals decreased average methylation levels years before breast cancer diagnosis | Q35914867 | ||
| Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170. | Q35940158 | ||
| Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer | Q35996692 | ||
| Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression | Q36066735 | ||
| An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression | Q36073563 | ||
| Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus | Q36086247 | ||
| Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus | Q36111237 | ||
| Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus | Q36124728 | ||
| Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer risk | Q36248936 | ||
| Breast cancer risk-associated SNPs modulate the affinity of chromatin for FOXA1 and alter gene expression | Q36354441 | ||
| A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. | Q36435849 | ||
| Prediction of breast cancer risk based on profiling with common genetic variants | Q36583004 | ||
| Breast Cancer Risk Prediction Using Clinical Models and 77 Independent Risk-Associated SNPs for Women Aged Under 50 Years: Australian Breast Cancer Family Registry | Q36619329 | ||
| Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33. | Q36670312 | ||
| Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers | Q36742577 | ||
| Genome-wide association analysis identifies three new breast cancer susceptibility loci | Q36842233 | ||
| Epigenome-wide association study of breast cancer using prospectively collected sister study samples | Q36843610 | ||
| Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer | Q36859142 | ||
| Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer | Q36897003 | ||
| GWAS3D: Detecting human regulatory variants by integrative analysis of genome-wide associations, chromosome interactions and histone modifications | Q36954041 | ||
| A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer | Q37218535 | ||
| Evaluation of potential regulatory function of breast cancer risk locus at 6q25.1. | Q37220500 | ||
| Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs). | Q37236216 | ||
| Lessons from postgenome-wide association studies: functional analysis of cancer predisposition loci | Q37241734 | ||
| Beyond GWASs: illuminating the dark road from association to function | Q37298148 | ||
| FGFR2 variants and breast cancer risk: fine-scale mapping using African American studies and analysis of chromatin conformation | Q37323340 | ||
| Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation | Q37342144 | ||
| Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. | Q37356243 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | genome-wide association study | Q1098876 |
| molecular medicine | Q3523816 | ||
| P304 | page(s) | 280 | |
| P577 | publication date | 2018-01-01 | |
| P1433 | published in | Frontiers in Genetics | Q2499875 |
| P1476 | title | Elucidating the Underlying Functional Mechanisms of Breast Cancer Susceptibility Through Post-GWAS Analyses | |
| P478 | volume | 9 |
Search more.